Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 69.08% institutional investors, 6.15% insiders, and 24.78% retail investors. Blackrock is the largest institutional shareholder, holding 16.01% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.73% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 69.08% | 6.15% | 24.78% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 18.69M | 16.01% | $289.58M |
| Blackrock funding, inc. /de | 18.63M | 15.19% | $434.75M |
| Vanguard group | 8.43M | 6.88% | $196.81M |
| State street | 6.41M | 5.24% | $126.19M |
| Deerfield management company, l.p. (series c) | 4.97M | 4.07% | $98.00M |
| Fundsmith llp | 3.36M | 2.75% | $66.27M |
| Dimensional fund advisors lp | 3.00M | 2.44% | $69.93M |
| Morgan stanley | 2.93M | 2.39% | $68.47M |
| Geode capital management | 2.90M | 2.37% | $67.70M |
| Renaissance | 2.65M | 2.16% | $61.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gables capital management | 424.62K | 4.19% | $9.91M |
| Tanaka capital management | 114.42K | 4.06% | $2.25M |
| Jw asset management | 388.39K | 2.95% | $9.07M |
| Knott david m jr | 189.00K | 2.04% | $4.41M |
| Deerfield management company, l.p. (series c) | 4.97M | 1.50% | $98.00M |
| Qsv equity investors | 36.01K | 1.24% | $840.47K |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Bridge city capital | 156.68K | 1.07% | $3.66M |
| Globeflex capital l p | 292.21K | 1.04% | $6.82M |
| Pvg asset management | 11.79K | 0.72% | $182.56K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 4.97M | 1.50% | 2.10M |
| Morgan stanley | 2.93M | 0.00% | 1.09M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| State street | 6.41M | 0.00% | 927.00K |
| American century companies | 2.53M | 0.03% | 770.20K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 2.65M | 0.10% | -894.75K |
| Macquarie group | - | - | -761.74K |
| Pacer advisors | - | - | -620.80K |
| Point72 asset management | - | - | -618.30K |
| Allianz asset management gmbh | 366.76K | 0.01% | -431.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 350.81K | 0.48% | 350.81K | $6.91M |
| Tanaka capital management | 114.42K | 4.06% | 114.42K | $2.25M |
| Empowered funds | 95.56K | 0.02% | 95.56K | $2.23M |
| Norges bank | 91.77K | 0.00% | 91.77K | $1.92M |
| Freestone grove partners lp | 60.74K | 0.01% | 60.74K | $1.20M |
Sold Out
| Holder | Change |
|---|---|
| Grey fox wealth advisors | -1.00 |
| Global financial private client | -1.00 |
| Jpl wealth management | -5.00 |
| Coppell advisory solutions | -8.00 |
| Mendota financial group | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 317 | -13.39% | 84,692,615 | -18.03% | 69 | 0.97% | 157 | -11.30% | 105 | -21.64% |
| Sep 30, 2025 | 351 | -3.57% | 103,180,919 | 1.77% | 84 | 1.23% | 169 | -19.52% | 129 | 5.74% |
| Jun 30, 2025 | 354 | -3.54% | 101,094,756 | 3.01% | 82 | 1.27% | 204 | 3.55% | 118 | -2.48% |
| Mar 31, 2025 | 361 | 6.80% | 97,419,101 | -0.16% | 80 | 1.19% | 193 | -4.46% | 119 | 33.71% |
| Dec 31, 2024 | 329 | 4.44% | 99,023,975 | 3.92% | 83 | 1.30% | 195 | 21.88% | 87 | -17.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.99M | 5.73% | -503.98K |
| Vanguard Total Stock Mkt Idx Inv | 3.68M | 3.01% | 10.79K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| Smithson Investment Trust Ord | 3.36M | 2.75% | - |
| Avantis US Small Cap Value ETF | 3.16M | 2.59% | 18.00K |
| iShares Russell 2000 ETF | 2.78M | 2.27% | 631.87K |
| State Street® SPDR® S&P® Biotech ETF | 2.67M | 2.19% | -14.31K |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.25M | 1.02% | 2.76K |
| Fidelity Small Cap Index | 1.17M | 0.95% | 2.23K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Harper Molly | - | Sell | $155.56K |
| Dec 12, 2025 | Harper Molly | - | Sell | $106.16K |
| Dec 12, 2025 | Harper Molly | - | Sell | $360.20K |
| Nov 26, 2025 | Del Carmen Jeffrey | Chief Commercial Officer | Sell | $256.24K |
| Nov 12, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Buy | $908.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 5 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools